Stephen Brannan - Karuna Therapeutics Chief Medical Officer

Dr.Stephen Brannan is Chief Medical Officer of company.r. Brannan is a neuroscience drug development expert who has held senior positions overseeing both clinical development and medical affairs with more than 15 years of industry experience. Previously, Dr. Brannan was the therapeutic head of Neuroscience at Takeda and vice president for clinical research and medical affairs at Forum Pharmaceuticals. Dr. Brannan was active in the development of multiple important central nervous system treatments including Cymbalta, Exelon Patch, Trintellix, and VNS for treatment resistant depression while holding various senior roles at Forum, Takeda, Novartis, Cyberonics, and Eli Lilly. His experience includes drug development, registration, medical affairs, launch and lifecycle management across psychiatry and neurology. Dr. Brannan is a board certified and is a member of several scientific societies and groups, including ISCTM, ISCDD, AARR, IOM Neuroforum, and CNS Summit . Prior to joining the pharmaceutical industry, Dr. Brannan worked on the faculty at the University of Texas Health Science Center at San Antonio where he specialized in seeing mood and anxiety disorder patients, ran a clinical research unit, and did neuroimaging research at the Research Imaging Center. Dr. Brannan trained in psychiatry at UTHSCSA and holds a M.D. degree from the University of Texas Health Science Center at Dallas . He has over 40 publications and routinely gives invited talks and presentation at industry conferences.